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Resistance to antibiotics has been acknowledged as a major global public health problem. The use of 
antimicrobial peptides to provide alternatives to combat multi-drug antibiotic resistance is beginning to 
attract increasing attention. The high diversity of amphibian skin peptides renders anurans an 
important potential source for the discovery of novel pharmacophores. This study aimed to investigate 
the antifungal activity of skin secretions from selected frogs (Amietia fuscigula, Strongylopus grayi and 
Xenopus laevis) and one toad (Amietophrynus pantherinus) of the south Western Cape Province of 
South Africa. Initially, different extraction techniques for the collection of skin secretions were tested 
and optimized, thereafter the extracts were tested against three fungal species of medical and 
agricultural importance that is, Candida albicans, Fusarium verticillioides and Aspergillus flavus. 
Chemical stimulation gave the best yield by mass, and secretions from A. fuscigula showed the best 
activity with an MIC of 40 µg / ml against C. albicans and 200 µg / ml against A. flavus. In general, C. 
albicans and A. flavus were the most sensitive while F. verticillioides was the most resistant. From this 
study it appears that bioprospecting of South African frog species has the potential to yield potential 
therapeutic lead agents. 
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Fungi are an important cause of human, animal and plant 
disease. Fungal infections in particular, have increased 
dramatically due to their opportunistic occurrence as a 
result of reduced immune status associated with the 
human immunodeficiency virus/ acquired immunode-
ficiency syndrome (HIV/AIDS) pandemic, cancer chemo-
therapy and transplantation surgery (Ascioglu et al., 
2002). In particular, oral and genital candidosis due to 
Candida albicans and related species is a significant 
cause of morbidity and mortality (Jarvis, 1995). 
Treatment is limited by the narrow range of effective 
antifungal agents available, their toxicity (Feldmesser, 
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2003), emergence of resistance strains (Klepser, 2001) 
and relapse and re-infection (De bruyne, 1997). 
With all the research focus on human disease, very little 
attention has been given to fungi and the toxins they 
produce that pose a threat to agriculture, and thereby 
cause disease in humans. Subsistence farming is 
widespread in rural Africa and is a strategy by poor rural 
households to reduce expenditure on food and ensure 
food security (Watkinson and Makgetla, 2002). Food 
production and storage therefore play an important role in 
stabilising seasonal food production (Bankole et al., 
2006).  
The fungus, Fusarium verticillioides, is one of the most 
common seed - borne fungi associated with corn / maize 
used for human and animal consumption throughout the 
world (Marasas et al., 1984). F. verticillioides and 
Fusarium moniliforme produce fumonisins which have 
been implicated as a risk factor in the development of 
oesophageal cancer in the Transkei region of South 
Africa as well as in the Cixian and Linxian counties of the 
People’s Republic of China (Sydenham et al., 1996) and 
is a cause of leukoencephalomalacia in horses and 
porcine pulmonary edema (PPE) (Marasas et al., 1988). 
More importantly fumonisin exposure has been asso-
ciated with neural tube defects (NTDs) (Marasas et al., 
2004). Another important fungus is Aspergillus flavus 
which grows on crops left on the ground or stored in poor 
conditions and produces the aflatoxin mycotoxins. 
Aflatoxins are field and storage mycotoxins which are 
potent carcinogens, mutagens and immuno-suppressing 
agents (Katerere et al., 2008). They can act in synergy 
with the Hepatitis B virus (HBV) to increase the risk of 
hepatocellular carcinoma (Bhat and Vasanthi, 2003). 
Perinatal exposure to aflatoxins has been shown to stunt 
growth (low height for age) and may contribute to infant 
mortality as a result of protein energy malnutrition (Gong 
et al., 2002). 
For centuries plants have been the major source of 
active compounds for pharmaceutical products 
(Springfield and Weitz, 2006). In recent years, the search 
for new pharmaceuticals of natural origin has intensified 
and been extended to include sources other than plant 
material (Clarke, 1997). The utilization of animal - based 
medicines also has a long history from ancient times 
(Weiss, 1947; Angeletti et al., 1992; Rosner, 1992) and 
scientists are increasingly exploring the use of meta-
bolites from animals for antimicrobial activity.  
Amphibians in particular offer an attractive source of 
novel antimicrobials because they exist in microorganism 
- rich environments, causing them to produce potent 
antimicrobial peptides (AMPs) as an innate form of 
defence (Govender et al., 2012). Given the respiratory 
and antimicrobial functions of the amphibian skin, it is 
likely that some of the molecules found in amphibian 
secretions may be of use in the treatment of skin and 
respiratory infections (Clarke, 1997). Extensive studies 





genus Rana (Che et al., 2008; Simmaco et al., 1998a). 
However there have been few studies on the 
antimicrobial activity of African frog species despite the 
large number of species and high endemicity which is 
typical of tropical West Africa, southern Africa and the 
Madagascari islands (Channing, 2001; Glaw and Vences, 
2007; Poynton, 1999; Rödel, 2000). South Africa alone is 
home to over 100 anuran species (Minter et al., 2004) of 
which nearly half are found in the Western Cape Province 
and 27 species are endemic to the south Western Cape 
region (De Villiers, 2008). This large diversity and density 
may correlate to a great molecular diversity creating high 
potential for the discovery of novel therapeutic peptides. 
This study aimed to extract and test secretions of frog 
and toad species found in the South Western Cape 
Province for antifungal activity. The first phase 
investigated the optimum extraction method. This method 
was then used to obtain secretions from three frog 
(Amietia fuscigula, Strongylopus grayi and Xenopus 
laevis) and one toad species (Amietophrynus 
pantherinus) which were then tested for activity against 








An application was made to and approved by the Cape Peninsula 
University of Technology (CPUT) Health and Applied Sciences 
Research Ethics committee. A permit from the Cape Nature 
Conservation of South Africa was obtained for the collection of the 
specimens used. Upon capture the species were identified by Dr 





A pond at the University of the Western Cape, Cape Town, South 
Africa, was identified for the collection of specimens of X. laevis. A 
total of 15 medium sized X. laevis frogs were collected, of which 12 
weighing between 22 and 30 g were randomly selected for the 
testing of extraction techniques. These specimens of frog were 
collected using a home-made bucket trap with a narrowing entry 
hole during May 2008. This entry hole is large enough to let the frog 
in but not out. Ox liver was used as bait to attract the frogs into the 
bucket. The bucket with ox liver in hosiery material was submerged 
overnight and then collected in the morning. All frogs captured, 
besides the three frogs used in the skin harvesting technique, were 
released back where they were collected. 
Four specimens from three species of frogs (A. fuscigula, S. grayi 
and X. laevis) and one toad species (A. pantherinus) were collected 
in the wild from the Oude Molen Village, Pinelands, Cape Town, 
South Africa during June 2008.  The numbers collected were limited 
by the number of frogs available. Frogs and collecting sites are 
illustrated in Figures 1 and 2. 
 
 
Evaluation of extraction techniques of frog and toad secretions 
 
The four techniques tested to extract the frog skin secretions were 
swabbing, physical stimulation, tissue harvesting and chemical 
stimulation. Three X. laevis were   used   for each technique. The 










extracts obtained were freeze-dried and then weighed and the yield 
calculated per body mass. The extracts were in each case re-
constituted into 100 ul of sterile distilled water. 
 
 
Swabbing - a novel approach  
 
This was a new method developed for this study. The dorsal 
surface of three frogs was massaged gently with a cotton swab. 
The swabs were then placed in Eppendorf tubes, sealed and stored 
at -20°C. A 100 µl of distilled water was used to wash off the 




Physical stimulation - a novel approach 
 
A frog was placed in a Ziploc
®
 bag with 30 ml of double distilled 
water as illustrated in Figure 3 and was shaken in the bag, gently 
for 5 min. The distilled water containing the skin secretions was 
then poured from the bag into 50 ml centrifuge tubes and an 
additional 10 ml of double distilled water that was used to rinse the 
frog in the bag was added to the 50 ml centrifuge tube. The 40 ml 




Tissue harvesting  
 
The tissue harvesting technique of Goraya et al. (2000) was 
modified in this study. Frogs were individually euthanized by placing 
the frog in a bottle that contained tricaine methane sulfonate (MS 
222) dissolved in distilled water. As much of the dorsal skin of the 
frogs was then removed and stored at -20°C. The tissue was homo- 
genized in 10 ml of distilled water and freeze dried.  
 
 
Chemical stimulation  
 
This technique was adapted from Che et al. (2008). Cotton wool 
was soaked in anhydrous ether and placed into a tube. An 
individual frog was placed in a clean 5 l glass bottle. The plastic test 
tube with the cotton wool soaked in anhydrous ether was put into 
the bottle and the lid was tightened. The frog was left in the bottle 
for 2 min. The plastic test tube was removed from the bottle and the 
frog was rinsed with 15 ml of buffer (0.1 M phosphate buffer, 
containing 5 mM ethylene diaminetetraacetic acid (EDTA), pH 6.0) 
to wash off the skin secretions. The buffer containing the secretions 
was then freeze-dried.  
 
 
Testing for anti-fungal activity 
 
Three fungal species of medical and agricultural importance were 
used viz: F. verticillioides (MRC 826), A. flavus (MRC 3954), C. 
albicans (MRC 8907). These fungi were obtained from the 
Programme on Mycotoxins and Experimental Carcinogenesis 
(PROMEC) Unit of the South African Medical Research Council 
(MRC).  The fungal isolates were grown on potato dextrose agar 
(PDA) for five days at 25°C and then stored in an incubator at 4°C. 
Fungal suspensions were prepared by suspending the spores in a 
solution of 0.05% tween 20. Prior to use, the suspensions were 
diluted in potato dextrose broth (PDB) standardized to 0.5 
McFarland. The microtitre plate method described in detail by 
Katerere and Eloff (2005) and Thembo and co-workers (2010) was 
used. The indicator ρ-INT was included at the beginning of the 
experiment and visual inspection of the plates was done every 24 h 
and MIC recorded for up to five days. 
 
Figure 1: A map of South Africa showing the location of the study site. 
 
 
Oude Molen, Pinelands 









Figure 2. Specimens collected from the Oude Molen area. A) Amietia fuscigula, B) Strongylopus grayi, C) 






Figure 3. The physical stimulation technique being applied to the X. laevis.  














Yield                    
(mg/g) 
AD 326 Ranidae Amietia fuscigula Cape River frog 80.08 140 1.75 





6.06 130 21.45 
AD 328 Ranidae Strongylopus grayi 
Clicking Stream 
frog 
10.28 80 7.78 






Extraction technique selection  
 
The amount of secretions obtained from the swabbing, 
skin harvesting and physical was so small that it was 
impossible to analyse using the sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) and the 
Bradford assays. In contrast, the chemical stimulation 
technique yielded a larger quantity of secretions which. A 
total of 50 mg was obtained which translated to a yield of 
0.66 mg/g. Due to its superiority and ease of use, the 
chemical stimulation method was selected as the method 
of choice for subsequent use. The four species collected 
and the yield obtained are shown in Table 1.  
A wide variation in the yield of secretions was 
observed. It would have been expected that the larger the 
frog the greater the skin surface area and number of 
secretory glands, therefore more secretions would be 
obtained. The results indicate that this was not the case. 
Unfortunately, due to the limitations on our collecting 
permit we could not collect more than one specimen for 
each species. It might be worth investigating whether the 
yield is repeatable with a larger sample size. 
In this study, the frogs were stimulated once and 
released back into their natural environment. Mangoni et 
al. (2001) stated that frogs that have been pharma-
cologically depleted of skin antimicrobial peptides will not 
easily recover unless the animals are gradually exposed 
to bacteria or fungi in their environment. In their depleted 
state these frogs will succumb to infection if suddenly 
exposed to otherwise innocuous microbes. This seems to 
indicate that AMPs are inducible rather than constitutive 
compounds.  
Antifungal activity for the different frog and toad species 
was found to be between 0.04 and 12.5 mg/ml (Table 2). 
Good inhibition was shown by all frog secretions on C. 
albicans with minimum inhibitory concentration (MIC) 
values of between 0.04 and 0.19 mg/ml after 120 h. 
Apparent biofilm formation was evident with C. albicans 
after 72 h of exposure to the extract. This makes the 
potency of extracts from A. fuscigula (AD 326) all the 
more interesting. Candida species are well known for 
biofilm formation which results in reduced sensitivity 
(d'Enfert, 2006). Similar results were obtained against A. 
flavus, where relatively low concentrations of 0.19 to 0.39 
mg/ml were obtained after five days. F. verticillioides was 
generally resistant to all extracts.  
In the case of isolates of Aspergillus spp. conidium 
formation was enhanced on plates after five days. 
Conidial formation may be an indication of stress and it 
might ironically result in increased biosynthesis of 
mycotoxin (Guzman-de-Penã and Ruiz-Herrera, 1997). In 
stability graphs, the lower and more horizontal (flatter) the 
curve, the better the activity of the test extract. A more 
horizontal line depicts fungicidal activity as opposed to 
fungistatic activity, that is, the ability of a test extract to 
inhibit fungi for a certain time and lose activity thereafter 
(Thembo et al., 2010). It is evident that the extracts are 
particularly stable and maybe fungicidal against C. 
albicans, with MIC not exceeding 0.19 mg / ml after five 





Frog skin secretions were previously obtained by either 
electrical stimulation (Dourado et al., 2007; Kim et al., 
2007; Nascimento et al., 2007), chemical stimulation 
using norepinephrine (Conlon et al., 2007; Nascimento et 
al., 2007; Rollins-Smith and Reinhart, 2005) or skin 
harvesting (Goraya et al., 2000; Roseghini et al., 1989). 
More recently the irritant chemical stimulation technique 
(Che et al., 2008) has been used to good effect. In the 
Che et al. (2008) study, 30 frogs of the same species 
were used, whereas in the present study a single frog 
provided sufficient yield for the bioassays. Furthermore, 
the skin secretions could be obtained in the field and the 
animals could be released at their site of capture. This 
reduced the amount of stress imposed on the frogs and 
ensured that the frogs were released back on their 
original collection sites.  
Following the discovery in 1987 of the magainins in 
skin secretions of the African clawed frog X. laevis 
(Zasloff, 1987), attention has been increasingly  focused  
upon   the   skins  of  anurans  as a potential source of 









































Amieta fuscigula (AD 326) 0.39 0.04 0.02 1.56 0.04 0.19 1.56 0.04 0.19 12.5 0.04 0.19 
Amietophrynus pantherinus
#
 (AD 327) 0.39 0.04 0.02 1.56 0.19 0.19 1.56 0.19 0.19 1.56 0.19 0.39 
Strongylopus grayi (AD 328) 0.39 0.04 0.02 3.12 0.09 0.09 3.12 0.19 0.09 12.5 0.64 0.39 
Xenopus laevis (AD 330) 0.39 0.02 0.02 3.12 0.09 0.09 3.12 0.19 0.09 12.5 0.19 0.39 
Amphotericin B*   0.52   1.17   6.38   21.0  
 
a
Fusarium verticillioides (MRC 826); 
b
Candida albicans (MRC 8907); 
c







novel antibiotics (Nicolas and Mor, 1995; Simmaco et al., 
1998b). Che et al. (2008) stated that the skin of 
amphibians, particularly those belonging to the families of 
Pipidae, Hylidae, Hyperoliidae, Pseudidae and Ranidae, 
synthesize and secrete a diverse array of antimicrobial 
peptides. Similar to the study of Zasloff (1987), the 
present study found that low concentrations of X. laevis 
secretions were able to inhibit growth of C. albicans. Skin 
secretions from the frog species A. fuscigula, 
(Pyxicephalidae), A. pantherinus (Bufonidae) and S. grayi 
(Pyxicephalidae) have not been previously tested for 
antifungal activity and this study is the first to do so. 
Peptides have been isolated from the skin secretions of 
toads belonging to the family Bufonidae (Clarke, 1997; 
Maciel et al., 2003, 2006) however, none of these studies 
focused on the species A. pantherinus or any other South 
African bufonid representatives.  
Previous studies have reported that secretions from 
Rana septentrionalis (Bevier et al., 2004), Rana areolata 
(Ali et al., 2002), Amolops loloensis (Wang et al., 2008) 
showed no activity against C. albicans. In the present 
study, the frog skin secretions were active against not 
only C. albicans but also A. flavus. Strains of Candida 
spp have been used in previous similar studies (Ali et al., 
2001; Basir et al., 2000; Wang et al., 2007) and the 
activity found ranged from 0.03 to >0.10 mg/ml. The 
results are similar to those obtained in this study. There is 
a need to isolate more secretions from the most active 
species, re-test them and isolate and elucidate the 






This study demonstrates the potential of finding novel 
antimicrobial peptides from anurans of the south Western 
Cape and South Africa. The use of peptides to provide 
alternative approaches to combating multi-drug resistant 
organisms is gaining momentum. This study presents a 
strong case for broadening research focus from biopros-
pecting for antimicrobials in medicinal plants to Africa’s 
amphibian species, which are largely unexplored and 
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